Characterization of a glycine receptor domain that controls the binding and gating mechanisms of the β‐amino acid agonist, taurine
- 1 November 2001
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 79 (3), 636-647
- https://doi.org/10.1046/j.1471-4159.2001.00601.x
Abstract
The beta-amino acid, taurine, is a full agonist of the human glycine receptor alpha1 subunit when recombinantly expressed in a mammalian (HEK293) cell line, but a partial agonist of the same receptor when expressed in Xenopus oocytes. Several residues in the Ala101-Thr112 domain have previously been identified as determinants of beta-amino acid binding and gating mechanisms in Xenopus oocyte-expressed receptors. The present study used the substituted cysteine accessibility method to investigate the role of this domain in controlling taurine-specific binding and gating mechanisms of glycine receptors recombinantly expressed in mammalian cells. Asn102 and Glu103 are identified as taurine and glycine binding sites, whereas Ala101 is eliminated as a possible binding site. The N102C mutation also abolished the antagonistic actions of taurine, indicating that this site does not discriminate between the putative agonist- and antagonist-bound conformations of beta-amino acids. The effects of mutations from Lys104-Thr112 indicate that the mechanism by which this domain controls beta-amino acid-specific binding and gating processes differs substantially depending on whether the receptor is expressed in mammalian cells or Xenopus oocytes. Thr112 is the only domain element in mammalian cell-expressed GlyRs which was demonstrated to discriminate between glycine and taurine.Keywords
This publication has 30 references indexed in Scilit:
- Kinetic and mutational analysis of Zn2+ modulation of recombinant human inhibitory glycine receptorsThe Journal of Physiology, 2000
- Identification of a New Ligand Binding Domain in the α1 Subunit of the Inhibitory Glycine ReceptorJournal of Neurochemistry, 1999
- Properties of human glycine receptors containing the hyperekplexia mutation α1(K276E), expressed in Xenopus oocytesThe Journal of Physiology, 1998
- The glycine receptorPharmacology & Therapeutics, 1997
- The inhibitory glycine receptor: architecture, synaptic localization and molecular pathology of a postsynaptic ion-channel complexCurrent Opinion in Neurobiology, 1995
- Mutation of an arginine residue in the human glycine receptor transforms β-alanine and taurine from agonists into competitive antagonistsNeuron, 1995
- Point mutation of glycine receptor α1 subunit in the spasmodic mouse affects agonist responsesFEBS Letters, 1994
- A missense mutation in the gene encoding the α1 subunit of the inhibitory glycine receptor in the spasmodic mouseNature Genetics, 1994
- Mutation of Glycine Receptor Subunit Creates β-Alanine Receptor Responsive to GABAScience, 1993
- Distinct agonist- and antagonist-binding sites on the glycine receptorNeuron, 1992